Comment for Type of Reporting Person:
The securities reported in rows 8, 10 and 11 are comprised of (i) 46,153,845 shares of Class A Common Stock, par value $0.00001 per share (the "Class A Common Stock") of Blend Labs, Inc. (the "Issuer") issuable upon conversion of 150,000 shares of Series A Convertible Preferred Stock, par value $0.00001 per share, (the "Series A Preferred Stock") of the Issuer, (ii) 11,111,112 shares of Class A Common Stock issuable upon exercise of warrants with an exercise price of $4.50 per share (the "Warrants") and (iii) 3,123,242 shares of Class A Common Stock.
The number of shares of Class A Common Stock outstanding for purposes of the percentage calculation in row 13 assumes (i) 255,696,747 shares outstanding as of July 31, 2025, as reported by the Issuer in its Quarterly Report for the period ended June 30, 2025, as filed with the Securities and Exchange Commission on August 7, 2025 (the "Q2 2025 10-Q"), (ii) 46,153,845 shares of Class A Common Stock issuable upon conversion of the Series A Preferred Stock and (iii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants.
Comment for Type of Reporting Person:
The securities reported in rows 8, 10 and 11 are comprised of (i) 46,153,845 shares of Class A Common Stock issuable upon conversion of 150,000 shares of Series A Preferred Stock, (ii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants and (iii) 3,123,242 shares of Class A Common Stock.
The number of shares outstanding for purposes of the percentage calculation in row 13 assumes (i) 255,696,747 shares outstanding as of July 31, 2025, as reported in the Q2 2025 10-Q, (ii) 46,153,845 shares of Class A Common Stock issuable upon conversion of the Series A Preferred Stock and (iii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants.
Comment for Type of Reporting Person:
The securities reported in rows 8, 10 and 11 are comprised of (i) 46,153,845 shares of Class A Common Stock issuable upon conversion of 150,000 shares of Series A Preferred Stock, (ii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants and (iii) 3,123,242 shares of Class A Common Stock.
The number of shares outstanding for purposes of the percentage calculation in row 13 assumes (i) 255,696,747 shares outstanding as of July 31, 2025, as reported in the Q2 2025 10-Q, (ii) 46,153,845 shares of Class A Common Stock issuable upon conversion of the Series A Preferred Stock and (iii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants.
Comment for Type of Reporting Person:
The securities reported in rows 8, 10 and 11 are comprised of (i) 46,153,845 shares of Class A Common Stock issuable upon conversion of 150,000 shares of Series A Preferred Stock, (ii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants and (iii) 3,123,242 shares of Class A Common Stock.
The number of shares outstanding for purposes of the percentage calculation in row 13 assumes (i) 255,696,747 shares outstanding as of July 31, 2025, as reported in the Q2 2025 10-Q, (ii) 46,153,845 shares of Class A Common Stock issuable upon conversion of the Series A Preferred Stock and (iii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants.
Comment for Type of Reporting Person:
The securities reported in rows 8, 10 and 11 are comprised of (i) 46,153,845 shares of Class A Common Stock issuable upon conversion of 150,000 shares of Series A Preferred Stock, (ii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants and (iii) 3,123,242 shares of Class A Common Stock.
The number of shares outstanding for purposes of the percentage calculation in row 13 assumes (i) 255,696,747 shares outstanding as of as of July 31, 2025, as reported in the Q2 2025 10-Q, (ii) 46,153,845 shares of Class A Common Stock issuable upon conversion of the Series A Preferred Stock and (iii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants.
Comment for Type of Reporting Person:
The securities reported in rows 8, 10 and 11 are comprised of (i) 46,153,845 shares of Class A Common Stock issuable upon conversion of 150,000 shares of Series A Preferred Stock, (ii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants and (iii) 3,123,242 shares of Class A Common Stock.
The number of shares outstanding for purposes of the percentage calculation in row 13 assumes (i) 255,696,747 shares outstanding as of July 31, 2025, as reported in the Q2 2025 10-Q, (ii) 46,153,845 shares of Class A Common Stock issuable upon conversion of the Series A Preferred Stock and (iii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants.
Comment for Type of Reporting Person:
The securities reported in rows 8, 10 and 11 are comprised of (i) 46,153,845 shares of Class A Common Stock issuable upon conversion of 150,000 shares of Series A Preferred Stock, (ii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants and (iii) 3,253,242 shares of Class A Common Stock, including 130,000 shares of Class A Common Stock held in a family trust for which Mr. Sheth's spouse is the trustee.
The number of shares outstanding for purposes of the percentage calculation in row 13 assumes (i) 255,696,747 shares outstanding as of July 31, 2025, as reported in the Q2 2025 10-Q, (ii) 46,153,845 shares of Class A Common Stock issuable upon conversion of the Series A Preferred Stock and (iii) 11,111,112 shares of Class A Common Stock issuable upon exercise of the Warrants.